Science Immunology, published by the American Association for the Advancement of Science, is a leading journal in the field of immunology, recognized for its significant impact and rigor in advancing our understanding of immune responses and complex diseases. With an impressive impact factor that places it in the Q1 category of both immunology and allergy, as well as miscellaneous medicine, this journal is ranked #7 and #8 in their respective Scopus categories, reflecting its high-quality research output. Since its inception in 2016, Science Immunology has been at the forefront of interdisciplinary immunological research, fostering crucial insights that link immunology with pressing health challenges. The journal is committed to providing open access to its content, ensuring that groundbreaking findings are accessible to a global audience of researchers, professionals, and students. Its anthology not only addresses fundamental immunological mechanisms but also enhances the dialogue on translational applications and therapeutic interventions, solidifying its position as an essential resource within the scientific community.

CURRENT OPINION IN IMMUNOLOGY is a prestigious journal dedicated to the dynamic field of immunology, published by CURRENT BIOLOGY LTD in the United Kingdom. With an ISSN of 0952-7915 and an E-ISSN of 1879-0372, this journal has been a cornerstone of scholarly communication since its inception in 1988 and continues to disseminate cutting-edge research and reviews aimed at advancing our understanding of immune responses. Holding a remarkable Q1 ranking in both Immunology and Allergy categories for 2023, it ranks impressively within the top percentiles in its field, securing 27th233 in Immunology and Allergy and 31st out of 236 in Immunology and Microbiology. Emphasizing high-impact research, the journal provides researchers, professionals, and students with valuable insights into emerging trends and critical developments. As a vital resource in immunological research, it serves as a platform for disseminating innovative findings, fostering collaboration, and enhancing scholarly exchange in a rapidly evolving scientific landscape.

XENOTRANSPLANTATION is a premier journal published by Wiley, dedicated to advancing the field of transplant medicine and immunology. Since its inception in 1994, this journal has provided a vital platform for researchers to disseminate groundbreaking studies and reviews, focusing on the complexities of xenotransplantation—the transplantation of organs and tissues from one species to another. With an impressive impact factor emphasizing its relevance, it has garnered recognition in the 2023 rankings, achieving Q1 status in the field of Transplantation and Q2 in Immunology. This positions it among the top journals, ranked #12 out of 54 in Transplantation and #102 out of 236 in Immunology, according to Scopus metrics. Despite being a subscription-based journal, its commitment to high-quality research ensures that it remains essential for professionals, researchers, and students seeking to innovate and facilitate progress in the increasingly critical area of organ transplantation. XENOTRANSPLANTATION is not just a journal; it is a crucial resource for fostering collaboration and knowledge in a field that continually shapes the future of medicine.

CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

Transplant Infectious Disease is a premier journal dedicated to advancing the understanding of infectious complications in transplant recipients, contributing significantly to the fields of Infectious Diseases and Transplantation. Published by Wiley in the United Kingdom, this journal boasts an impressive reputation within the academic community, holding a 2023 Q2 quartile ranking in both Infectious Diseases and Transplantation, as well as notable Scopus rankings that position it among the top tiers of its categories. With a convergence of scholarly articles and research findings from 1999 through 2024, Transplant Infectious Disease serves as a critical resource for researchers, professionals, and students seeking to explore the intersection of transplantation and infectious diseases. The journal encourages open dialogue and knowledge dissemination through rigorous peer-reviewed content, making it an essential platform for those aiming to address the challenges and innovations in transplant medicine.

Experimental and Clinical Transplantation is a distinguished journal published by Baskent University in Turkey, dedicated to advancing the field of transplantation through innovative research and clinical insights. Established in 2003, the journal has rapidly gained recognition within the academic community, currently holding a Q3 ranking in the field of Transplantation for 2023, as evidenced by its position in the Scopus ranking for the discipline. With an emphasis on both experimental and clinical studies, this journal serves as a crucial platform for sharing breakthroughs in transplant medicine, immunology, and post-operative care strategies. Although it operates under a restricted access policy, the journal seeks to bridge the gap between research findings and practical applications in clinical settings, making it invaluable for researchers, healthcare professionals, and students alike who are keen on exploring advancements in the transplantation landscape. Through its commitment to quality and innovation, Experimental and Clinical Transplantation contributes significantly to enhancing patient outcomes and fostering scholarly dialogue in the transplantation community.

Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.

American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.